Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Capital Expenditures (2022 - 2026)

TriSalus Life Sciences has reported Capital Expenditures over the past 5 years, most recently at $141000.0 for Q1 2026.

  • For Q1 2026, Capital Expenditures fell 81.3% year-over-year to $141000.0; the TTM value through Mar 2026 reached -$545000.0, down 149.59%, while the annual FY2025 figure was $68000.0, 80.29% down from the prior year.
  • Capital Expenditures for Q1 2026 was $141000.0 at TriSalus Life Sciences, up from $5000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $754000.0 in Q1 2025 and troughed at -$734000.0 in Q2 2025.
  • A 5-year average of $122363.6 and a median of $141000.0 in 2026 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: surged 82.35% in 2023 and later tumbled 98.55% in 2025.
  • Year by year, Capital Expenditures stood at $204000.0 in 2022, then surged by 82.35% to $372000.0 in 2023, then dropped by 7.26% to $345000.0 in 2024, then tumbled by 98.55% to $5000.0 in 2025, then soared by 2720.0% to $141000.0 in 2026.
  • Business Quant data shows Capital Expenditures for TLSI at $141000.0 in Q1 2026, $5000.0 in Q4 2025, and $43000.0 in Q3 2025.